Safety Profile of Selective Serotonin Reuptake Inhibitors in Real-World Settings: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System.
Article in Annals of Pharmacotherapy (February 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Annals of Pharmacotherapy (February 2024)
Article in British Journal of General Practice (August 2023)
Article in The Medical Journal of Australia (June 2023)